FIELD: medicine.
SUBSTANCE: invention refers to medicine and may be used for treating acid-dependent conditions associated with H. Pylori. A complex therapy is used. Nuforoxazide suspension 10-12 ml/kg/day; cimetidine 250-300 mg/day; bismuth tripotassium dicitrate 480-720 mg/day; tetracycline 1-1.5 g/day and bifiform 2 capsules 3 times a day. The length of treatment is 1.5-2 weeks.
EFFECT: method enables higher clinical effectiveness.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ERADICATION OF GASTRIC AND DUODENAL HELICOBACTER PYLORI | 2006 |
|
RU2319523C2 |
METHOD FOR DETECTING EFFICIENCY OF APITHERAPY IN CASE OF ULCEROUS DUODENAL DISEASE | 2003 |
|
RU2247568C1 |
METHOD FOR PREDICTING GASTRIC AND DUODENAL PEPTIC ULCER CASES | 2003 |
|
RU2241228C1 |
METHOD OF TREATING PERIODONTITIS AND ORAL MUCOSAL DISEASES ASSOCIATED WITH HELICOBACTER INFECTION, AND METHOD FOR USING IT | 2014 |
|
RU2549445C1 |
METHOD OF TREATING GASTRIC ULCER DISEASE | 2007 |
|
RU2354373C1 |
METHOD FOR TREATMENT OF STOMACH AND DUODENUM ULCEROUS DISEASE | 2003 |
|
RU2240119C1 |
METHOD FOR TREATING HELICOBACTER PYLORI-ASSOCIATED ULCEROUS GASTRIC AND DUODENAL DISEASE | 2006 |
|
RU2308949C1 |
METHOD FOR PREDICTING THE FLOW OF GASTRIC AND DUODENAL ULCEROUS DISEASE | 2003 |
|
RU2246731C1 |
METHOD OF TREATING PYLORIC HELICOBACTERIOSIS | 2012 |
|
RU2506076C1 |
METHOD FOR TREATMENT OF HELICOBACTER-ASSOCIATED STOMACH AND DUODENUM INTESTINE ULCEROUS DISEASE | 2004 |
|
RU2278685C1 |
Authors
Dates
2012-04-10—Published
2011-02-24—Filed